Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts rolling review of COVID-19 vaccine Vidprevtyn 20 July 2021NewsHumanCOVID-19Vaccines EMA starts evaluating the use of Kineret in adult COVID-19 patients at increased risk of severe respiratory failure 19 July 2021NewsHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 July 2021 16 July 2021NewsVeterinaryMedicines International regulators work towards alignment on development and authorisation of second-generation COVID-19 vaccines 16 July 2021NewsHumanCOVID-19Vaccines EMA and ECDC update on COVID-19 14 July 2021NewsHumanCOVID-19Vaccines Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis 9 July 2021NewsHumanCOVID-19Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021 9 July 2021NewsHumanCOVID-19PharmacovigilanceReferrals EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome 9 July 2021NewsHumanCOVID-19Vaccines EMA finds no evidence linking viral vector in Zynteglo to blood cancer 9 July 2021NewsHumanMedicines Increased manufacturing capacity for COVID-19 Vaccine Janssen 2 July 2021NewsHumanCOVID-19Vaccines 1 … 57 58 59 60 61 Page 61 of 380 62 63 64 65 … 380
EMA starts evaluating the use of Kineret in adult COVID-19 patients at increased risk of severe respiratory failure 19 July 2021NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 July 2021 16 July 2021NewsVeterinaryMedicines
International regulators work towards alignment on development and authorisation of second-generation COVID-19 vaccines 16 July 2021NewsHumanCOVID-19Vaccines
Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis 9 July 2021NewsHumanCOVID-19Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021 9 July 2021NewsHumanCOVID-19PharmacovigilanceReferrals
EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome 9 July 2021NewsHumanCOVID-19Vaccines